         Sentence I: The U.S. Food and Drug Administration  rejected ImClone 's original application in  December 2001, saying the trial had been sloppily  conducted.    Sentence 2: The food and Drug Administration  ultimately denied ImClone 's drug application in  December 2001 , saying that an érbituy clinical  trial was deficient.